New Shot-Based combo aims to ease myeloma treatment burden

This study tests a new way to give a drug called isatuximab as a quick shot under the skin, instead of a long IV drip, for people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. The shot is combined with three standard chemotherapy drugs. The goal is to see if this easier-to-take combination works as well as the IV version in controlling the cancer. About 74 participants aged 65 and older will take part across French centers.